FAS and metabolic dysfunction-associated steatotic liver disease: In conclusion, MFE alleviated NAFLD by modulating the intestinal flora, especially the abundance of probiotic species; by improving the intestinal environment; by regulating intestinal tryptophan metabolism; by activating AhR in the liver; and by regulating the expression of the downstream targets FAS and SREBP-1c.